There may be no better example of the promise and pitfalls of so-called personalized medicine -- tailoring treatments to individual genetic traits -- than the test Genomic Health developed for breast-cancer patients like Katherine Young. [...] Despite widespread hopes that mapping the human genome this decade would usher in a flood of drugs for genetically similar patients, few such products have hit the market, largely because of fears that insurers won't cover their cost.